Teijin will participate in regeneration medicine of bone and cartilage by utilizing its accumulated nanotechnology by 2020. The company will develop a technology to fill in a defective part of a bone and cartilage with a thread made of a medical agent and a biological absorption polymer for faster regeneration of the defective part. Teijin’s accumulated nanofiber technology is advanced enough to utilize a thread 700 nanometers in diameter. It has been developing the next-generation medical materials that enhance treatment effect in combination with the existing medical treatment.
It has also been studying a technology to facilitate the regeneration of bone and cartilage and working on preclinical trials in collaboration with Kobe University and Osaka Prefecture University. They plan to start clinical study in 2014 at the earliest. This technology is supposed to be effective to the treatment of bone hard to regenerate. Teijin also opened up the road to a practical use of a microneedle in which plastic fine needles of several micrometers long each are aligned in the high density. The microneedle is helpful to deliver efficacy through skin efficiently. The company is scheduled to put this technology into practical use after 2020.